1. Home
  2. TRAK vs ADAG Comparison

TRAK vs ADAG Comparison

Compare TRAK & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

HOLD

Current Price

$7.51

Market Cap

144.0M

Sector

Technology

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$4.62

Market Cap

146.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRAK
ADAG
Founded
1990
2011
Country
United States
China
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.0M
146.3M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
TRAK
ADAG
Price
$7.51
$4.62
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
135.3K
228.3K
Earning Date
05-14-2026
03-24-2026
Dividend Yield
1.05%
N/A
EPS Growth
20.69
N/A
EPS
0.18
N/A
Revenue
$21,007,076.00
N/A
Revenue This Year
$6.61
$3,688.61
Revenue Next Year
$10.04
$17.39
P/E Ratio
$42.22
N/A
Revenue Growth
4.84
N/A
52 Week Low
$6.94
$1.34
52 Week High
$23.72
$4.58

Technical Indicators

Market Signals
Indicator
TRAK
ADAG
Relative Strength Index (RSI) 34.46 68.51
Support Level N/A $1.69
Resistance Level $9.02 N/A
Average True Range (ATR) 0.34 0.48
MACD 0.04 0.03
Stochastic Oscillator 44.27 98.44

Price Performance

Historical Comparison
TRAK
ADAG

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: